| Application no. and date | 12169694.2 (espacenet) (Federated) (European Patent Register), 20041021 | | Patent/reg. no. and date | DK/EP 2495251, 20140416 | | Publication date | 20120905 | | Priority no. and date | US 513359 P, 20031022 | | EP pub. no. and date |
EP 2495251 20120905 | | Effective date | | | Applicant/owner | Theravance Biopharma Antibiotics IP, LLC, 901 Gateway Boulevard
South San Francisco, CA 94080, US | | Applicant ref. no. | NGC/AP/149003 | | Inventor | LEE, Junning, 822 San Carlos Avenue
El Granada, CA 94018, US,
LIU, Jyanwei, 681 Endicott Drive
Sunnyvale, CA 94087, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | C07K 9/00 (2006.01) | | Title | Hydrochloridsalte af et glycopeptidphosphonatderivat | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
